WIMM Professor Ahmed Ahmed, along with Martin Drysdale from the Beatson Institute in Glasgow and Stefan Knapp (TDI, Oxford) have been awarded a substantial DPFS (Developmental Pathway Funding Scheme) grant (~£1.9M) from the MRC. The grant will support intensive medicinal chemistry efforts, structural biology and preclinical evaluation to develop novel small molecule inhibitor of SIK2 for ovarian cancer therapy.
